Companies /Healthcare

Rallybio Corp

NASDAQ: RLYB Biotechnology

$17.18

▲ $0.19 (+1.12%) today

Markets open · 11:45am ET

RLYB at a Glance

Valuation

Market cap: $90.3M
P/E ratio: 2.1

Profitability

Revenue (TTM): $646,000
Profit margin: 7,051.0%
EPS (TTM): $8.01

Price

52-week range: $4 – $18
Street target: $8.00

Earnings

Next report: Nov 5, 2026

Headquartered in New Haven, CT Fiscal year ends December NASDAQ: RLYB rallybio.com

About Rallybio

None

RLYB Coverage

10:05am ET

Investing

Stock Splits Matter: Notable Splits in 2025 and What’s Happening in 2026

Here is a look at why companies split their stocks and why it matters, with context on the major splits of 2025 and 2026 including Netflix, ServiceNow, Booking Holdings, and KLA Corporation.

AAPL AMZN CMG

Trey Thoelcke

Frequently Asked Questions

What does Rallybio do?

None

What is the RLYB stock price target?

The Wall Street consensus 12-month price target for RLYB is $8.00.